![]() |
Volumn 88, Issue 4, 2010, Pages
|
Intravitreal bevacizumab for retinal capillary haemangioma: Longterm results
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
VASCULOTROPIN;
ABSENCE OF SIDE EFFECTS;
ADULT;
BRAIN HEMANGIOMA;
CAPILLARY HEMANGIOMA;
CASE REPORT;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HEMANGIOMA;
HUMAN;
JUXTAPAPILLARY HEMANGIOMA;
KIDNEY HEMANGIOMA;
LASER COAGULATION;
LETTER;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RETINA MACULA EDEMA;
RETINA TELANGIECTASIA;
SCAR FORMATION;
VISUAL ACUITY;
VON HIPPEL LINDAU DISEASE;
ADULT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
FEMALE;
FOLLOW-UP STUDIES;
HEMANGIOMA, CAPILLARY;
HUMANS;
INJECTIONS;
RETINAL NEOPLASMS;
RETREATMENT;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITREOUS BODY;
VON HIPPEL-LINDAU DISEASE;
|
EID: 77952825645
PISSN: 1755375X
EISSN: 17553768
Source Type: Journal
DOI: 10.1111/j.1755-3768.2009.01594.x Document Type: Letter |
Times cited : (32)
|
References (5)
|